Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data

• Asıl Yazarlar: Ali Ekin (Yazar), Salim Misirci (Yazar), Selin İldemir (Yazar), Belkıs Nihan Coskun (Yazar), Burcu Yagiz (Yazar), Ediz Dalkilic (Yazar), Yavuz Pehlivan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2024-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Tofacitinib is a targeted JAK inhibitor used to treat rheumatoid arthritis. Despite some recent safety concerns, it is considered effective and safe with appropriate patient selection. Between May 2015 and May 2024, data were retrospectively analyzed from 112 patients with a diagnosis of RA...